Inspire Investing, LLC Halozyme Therapeutics, Inc. Transaction History

Inspire Investing, LLC

$959 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$33.32 - $42.1 $78,835 - $99,608	2,366 Added 29.56%	10,370 $383,000
Q3 2023 Oct 26, 2023	SELL	$36.46 - $44.03 $23,881 - $28,839	-655 Reduced 7.56%	8,004 $305,000
Q2 2023 Jul 31, 2023	BUY	$30.28 - $38.74 $46,812 - $59,892	1,546 Added 21.73%	8,659 $312,000
Q1 2023 Apr 24, 2023	BUY	$32.86 - $55.7 $97,988 - $166,097	2,982 Added 72.19%	7,113 $271,000
Q4 2022 Jan 26, 2023	SELL	$40.06 - $59.44 $42,864 - $63,600	-1,070 Reduced 20.57%	4,131 $0
Q3 2022 Nov 07, 2022	BUY	$38.53 - $51.78 $17,723 - $23,818	460 Added 9.7%	5,201 $206,000
Q2 2022 Aug 10, 2022	SELL	$37.35 - $48.3 $43,923 - $56,800	-1,176 Reduced 19.87%	4,741 $209,000
Q1 2022 Apr 21, 2022	SELL	$31.97 - $41.06 $6,042 - $7,760	-189 Reduced 3.1%	5,917 $236,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $194,292 - $248,819	6,106 New	6,106 $246,000
Q4 2021 Feb 03, 2022	SELL	$31.82 - $40.75 $184,810 - $236,676	-5,808 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$38.47 - $46.42 $223,433 - $269,607	5,808 New	5,808 $236,000
Q1 2021 Apr 30, 2021	SELL	$39.51 - $51.45 $653,416 - $850,880	-16,538 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $426,845 - $721,387	16,538 New	16,538 $706,000
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $252,149 - $290,255	-9,796 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$16.25 - $26.81 $61,116 - $100,832	-3,761 Reduced 27.74%	9,796 $263,000
Q1 2020 May 08, 2020	BUY	$13.9 - $21.83 $188,442 - $295,949	13,557 New	13,557 $244,000
Q4 2019 Jan 24, 2020	SELL	$14.93 - $19.53 $171,724 - $224,634	-11,502 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$15.2 - $17.69 $20,322 - $23,651	1,337 Added 13.15%	11,502 $178,000
Q2 2019 Jul 16, 2019	BUY	$14.75 - $17.26 $149,933 - $175,447	10,165 New	10,165 $175,000
Q1 2018 Apr 13, 2018	SELL	$17.06 - $21.2 $49,303 - $61,268	-2,890 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$16.75 - $20.8 $48,407 - $60,112	2,890	2,890 $59,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$930 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$681 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$350 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$215 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$180 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Account